Citations

Clear

6273 citation(s) found for "To, Andrew".

The Antibacterial Resistance Leadership Group: Scientific Advancements and Future Directions
Chambers, Henry F. , Cross, H. R. , Souli, Maria , Patel, Robin , Fowler, Vance G. , Group, for the Antibacterial Resistance Leadership, Deckard, Nancie , Schuler, Carl, Bunn, Ivra, Zaharoff, Smitha, Sharma, Shrabani, Wickward, Cathy, Waller, Jason, Wilson, Holly, Baum, Keri, Komarow, Lauren , Evans, Beth , Hopkins, D. E., Ge, Lizhao , Giri, Abhigya, Dai, Weixiao , Diao, Guoqing , Fidler, Tamara, Shao, Wanying, Schwager, Nyssa, Mau, Donald, Satlin, Michael J. , Schooley, Robert T. , Sund, Zoë, Booth, Grant, Estes, Leslie, Greenwood‐Quaintance, Kerryl E. , Parmar, Krupa , Doernberg, Sarah B. , Raza, Praneeta , Zeng, Lijuan , Banerjee, Ritu , Abbenante, Erin, Mocka, Elizabeth, King, H. A. , Kinamon, Tori, Boucher, Helen W., Geres, Holly, He, Yijie, Mehigan, Maureen, Ghazaryan, Varduhi , Raterman, Erica L., Samuel, Tamika, Lee, Marina S. , Fowler, Vance G. , Patel, Robin , Evans, Scott R , Cross, Heather R, Evans, Scott , Group, for the Antibacterial Resistance Leadership, Lodise, Thomas P. , Schuler, Carl, Holland, Thomas L , Turner, Nicholas , Wilson, Holly, van Duin, David , Wang, Minggui, Evans, Beth, Hopkins, Deborah, Bonomo, Robert A. , Li, Yixuan , Tamma, Pranita D. , Hamasaki, Toshimitsu , Cunningham, Scott A. , Dodd, Andrew, Tsalik, Ephraim L. , Tillekeratne, L. Gayani , King, Heather, Kinamon, Tori, Howard‐Anderson, Jessica , Nayak, Seema , Samuel, Tamika

Mayo Clinic

Clinical Infectious Diseases | October 16, 2023 | Volume: 77 | Issue: Supplement_4 | Pages: S279-S287

10.1093/cid/ciad475 | PMID 37843121 Get It

AbstractIn this overview, we describe important contributions from the Antibacterial Resistance Leadership Group (ARLG) to patient care, clinical trials design, and mentorship while outlining future priorities. The ARLG research agenda is focused on 3 key areas: gram-positive infections, gram-negative infections, and diagnostics. The ARLG has developed an innovative approach to clinical trials design, the desirability of outcome ranking (DOOR), which uses an ordinal measure of global outcome to assess both benefits and harms. DOOR was initially applied to observational studies to determine optimal dosing of vancomycin for methicillin-resistant Staphylcococcus aureus bacteremia and the efficacy of ceftazidime-avibactam versus colistin for the treatment of carbapenem-resistant Enterobacterales infection. DOOR is being successfully applied to the analysis of interventional trials and, in collaboration with the US Food and Drug Administration (FDA), for use in registrational trials. In the area of diagnostics, the ARLG developed Master Protocol for Evaluating Multiple Infection Diagnostics (MASTERMIND), an innovative design that allows simultaneous testing of multiple diagnostic platforms in a single study. This approach will be used to compare molecular assays for the identification of fluoroquinolone-resistant Neisseria gonorrhoeae (MASTER GC) and to compare rapid diagnostic tests for bloodstream infections. The ARLG has initiated a first-in-kind randomized, double-blind, placebo-controlled trial in participants with cystic fibrosis who are chronically colonized with Pseudomonas aeruginosa to assess the pharmacokinetics and antimicrobial activity of bacteriophage therapy. Finally, an engaged and highly trained workforce is critical for continued and future success against antimicrobial drug resistance. Thus, the ARLG has developed a robust mentoring program targeted to each stage of research training to attract and retain investigators in the field of antimicrobial resistance research.
Priorities and Progress in Diagnostic Research by the Antibacterial Resistance Leadership Group
Hanson, Kimberly E. , Banerjee, Ritu , Doernberg, Sarah B. , Komarow, Lauren , Satlin, Michael J. , Schwager, Nyssa, Simner, Patricia J. , Patel, Robin , Group, for the Antibacterial Resistance Leadership, Abbenante, Erin, Baum, Keri, Souli, Maria , Mocka, Elizabeth, Hopkins, D. E., Giri, Abhigya, Zeng, Lijuan , Greenwood‐Quaintance, Kerryl E. , Booth, Grant, Waller, Jason, Raza, Praneeta , Sund, Zoë, Wickward, Cathy, Dai, Weixiao , Ghazaryan, Varduhi , Raterman, Erica L., Samuel, Tamika, Lee, Marina S. , Patel, Robin , Evans, Scott R , Hanson, Kimberly , Evans, Scott , Tillekeratne, L. Gayani , Group, for the Antibacterial Resistance Leadership, Tsalik, Ephraim L. , Hopkins, Deborah, Dodd, Andrew, Li, Yixuan , Hamasaki, Toshimitsu , Samuel, Tamika

Mayo Clinic

Clinical Infectious Diseases | October 16, 2023 | Volume: 77 | Issue: Supplement_4 | Pages: S314-S320

10.1093/cid/ciad541 | PMID 37843119 Get It

Abstract The advancement of infectious disease diagnostics, along with studies devoted to infections caused by gram-negative and gram-positive bacteria, is a top scientific priority of the Antibacterial Resistance Leadership Group (ARLG). Diagnostic tests for infectious diseases are rapidly evolving and improving. However, the availability of rapid tests designed to determine antibacterial resistance or susceptibility directly in clinical specimens remains limited, especially for gram-negative organisms. Additionally, the clinical impact of many new tests, including an understanding of how best to use them to inform optimal antibiotic prescribing, remains to be defined. This review summarizes the recent work of the ARLG toward addressing these unmet needs in the diagnostics field and describes future directions for clinical research aimed at curbing the threat of antibiotic-resistant bacterial infections.
Spinal Meningeal Mass Lesion
White, Jessica D. , Sener, Uğur , Sener, Ugur , White, Jessica D., Clarke, Michelle J. , Paludo, Jonas , Feldman, Andrew L.

Mayo Clinic

The Neurologist | October 15, 2023 | Volume: 29 | Issue: 2 | Pages: 122-125

10.1097/nrl.0000000000000535 | PMID 37839092 Get It

Introduction: The differential diagnosis of a spinal intradural extramedullary mass lesion is broad and includes meningioma, schwannoma, neurofibroma, leptomeningeal metastasis, and myxopapillary ependymoma. Though rare, lymphoma should be included in the differential diagnosis of a dural mass lesion. Case Report: A 38-year-old man presented with back pain that progressed over 1 month with associated focal tenderness over his mid to lower thoracic spine. He developed intermittent numbness of the bilateral lower extremities, nuchal rigidity, difficulty sleeping, and night sweats. A magnetic resonance imaging of the thoracic spine demonstrated a dorsal intradural extramedullary enhancing lesion from T7 to T10 extending outside the spinal canal. Dural thickening across the entire circumference of the spinal cord was noted. Computed tomography (CT)-guided biopsy of the thoracic lesion was performed, and pathology was consistent with follicular lymphoma. Fluorodeoxyglucose positron emission tomography:CT demonstrated no systemic disease. Bone marrow biopsy was negative for malignancy. Symptoms resolved with dexamethasone therapy. He was treated with bendamustine and rituximab with follow-up positron emission tomography:CT 2 months later demonstrating a complete response. Conclusions: Lymphoma can rarely present as an isolated dural lesion and should be considered in the differential diagnosis of intradural extramedullary spinal mass lesions. Prompt diagnosis and initiation of treatment can lead to complete response and resolution of symptoms.
Treatment of intramedullary spinal cord tumors: a modified Delphi technique of the North American Spine Society Section of Spine Oncology
Pennington, Zach , Elsamadicy, Aladine A. , Dea, Nicolas , Desai, Atman , Gokaslan, Ziya L. , Hsu, Wesley , Krishnaney, Ajit A., Laufer, Ilya , Lo, Sheng-Fu Larry , Macki, Mohamed, Mehta, Ankit I. , Ozturk, Ali K. , Sciubba, Daniel M. , Pennington, Zach , Hersh, Andrew M. , Lubelski, Daniel , Goodwin, C. Rory , Jallo, George I. , Shin, John H. , Soliman, Hesham Magdi

Mayo Clinic

Journal of Neurosurgery: Spine | October 13, 2023 | Volume: 40 | Issue: 1 | Pages: 1-10

10.3171/2023.8.spine23190 | PMID 37856379 Get It

OBJECTIVE Intramedullary spinal cord tumors (IMSCTs) are rare tumors with heterogeneous presentations and natural histories that complicate their management. Standardized guidelines are lacking on when to surgically intervene and the appropriate aggressiveness of resection, especially given the risk of new neurological deficits following resection of infiltrative tumors. Here, the authors present the results of a modified Delphi method using input from surgeons experienced with IMSCT removal to construct a framework for the operative management of IMSCTs based on the clinical, radiographic, and tumor-specific characteristics. METHODS A modified Delphi technique was conducted using a group of 14 neurosurgeons experienced in IMSCT resection. Three rounds of written correspondence, surveys, and videoconferencing were carried out. Participants were queried about clinical and radiographic criteria used to determine operative candidacy and guide decision-making. Members then completed a final survey indicating their choice of observation or surgery, choice of resection strategy, and decision to perform duraplasty, in response to a set of patient- and tumor-specific characteristics. Consensus was defined as ≥ 80% agreement, while responses with 70%–79% agreement were defined as agreement. RESULTS Thirty-six total characteristics were assessed. There was consensus favoring surgical intervention for patients with new-onset myelopathy (86% agreement), chronic myelopathy (86%), or progression from mild to disabling numbness (86%), but disagreement for patients with mild numbness or chronic paraplegia. Age was not a determinant of operative candidacy except among frail patients, who were deemed more suitable for observation (93%). Well-circumscribed (93%) or posteriorly located tumors reaching the surface (86%) were consensus surgical lesions, and participants agreed that the presence of syringomyelia (71%) and peritumoral T2 signal change (79%) were favorable indications for surgery. There was consensus that complete loss of transcranial motor evoked potentials with a 50% decrease in the D-wave amplitude should halt further resection (93%). Preoperative symptoms seldom influenced choice of resection strategy, while a distinct cleavage plane (100%) or visible tumor-cord margins (100%) strongly favored gross-total resection. CONCLUSIONS The authors present a modified Delphi technique highlighting areas of consensus and agreement regarding surgical management of IMSCTs. Although not intended as a substitute for individual clinical decision-making, the results can help guide care of these patients. Additionally, areas of controversy meriting further investigation are highlighted.
Analysis of In-Season External Load and Sport Performance in Women’s Collegiate Basketball
Brown, Faith S. A. , Fields, Jennifer B. , Baker, Robert E., Jones, Margaret T. , Jones, Margaret T , Jagim, Andrew R.

Mayo Clinic

Journal of Strength & Conditioning Research | October 11, 2023 | Volume: 38 | Issue: 2 | Pages: 318-324

10.1519/jsc.0000000000004636 | PMID 37820260 Get It

Abstract Brown, FSA, Fields, JB, Jagim, AR, Baker, RE, and Jones, MT. Analysis of in-season external load and sport performance in women’s collegiate basketball. J Strength Cond Res 38(2): 318–324, 2024—Quantifying and monitoring athlete workload throughout a competitive season is a means to manage player readiness. Therefore, the purpose of the current study was to quantify practice and game external loads and to assess the relationship between such loads and basketball-specific performance metrics across a women's collegiate basketball season. Thirteen National Collegiate Athletic Association Division I women basketball athletes (age 20.08 ± 1.55 years) wore Global Positioning Systems sensors equipped with triaxial accelerometers for 29 games and 66 practices during the 2019–20 season. A multivariate analysis of variance was used to assess differences in external load between high- and low-minute players and across quarters within games ( p < 0.05). Bivariate Pearson correlation coefficients were run to determine relationships between external loads and metrics of basketball performance. Findings indicated that high- and low-minute athletes experienced different loads during games and practices ( p < 0.001). External loads differed by quarter, such that player load (PL) was highest in Q4 ( p = 0.007), PL·min −1 was highest in Q1 and lowest in Q4 ( p < 0.001), and explosive ratio (i.e., ratio of PL and explosive efforts) was lowest in Q3 ( p = 0.45). Relationships existed between PL·min −1 and field goals ( r = 0.41; p = 0.02) and between the explosive ratio and free throws ( r = 0.377 p = 0.04). These results can be used to inform design of training sessions with the intent to prepare athletes for the demands of the competitive season. It is recommended that future research continue to explore the relationship of sport-specific performance metrics and athlete external load.
Correction to: Endoscopic Ultrasound-Guided Gastrojejunostomy for Superior Mesenteric Artery Syndrome Secondary to Rapid Weight Loss
Alqaisieh, Mohammad , Mahmoud, Tala , Akiki, Karl, Law, Ryan , Law, Ryan J, Storm, Andrew C.

Mayo Clinic

ACG Case Reports Journal | October 11, 2023 | Volume: 9 | Issue: 11 | Pages: e00914

10.14309/crj.0000000000000914 | PMID 36397884 Get It

GADD45A is a mediator of mitochondrial loss, atrophy, and weakness in skeletal muscle
Marcotte, George R. , Miller, Matthew J. , Ryan, Zachary C. , Strub, Matthew D. , Vanderboom, Patrick M. , Heppelmann, Carrie J. , Chau, Sarah, Ruff, Zachary D. Von, Kilroe, Sean P. , McKeen, Andrew T., Dierdorff, Jason M., Stern, Jennifer I. , Nath, Karl A. , Ebert, Scott M. , Adams, Christopher M. , Ebert, Scott M. , Adams, Christopher M , Kunz, Hawley , Chau, Sarah, Grueter, Chad Eric , Lira, Vitor Agnew , Judge, Andrew R. , Rasmussen, Blake B. , Nair, K. Sreekumaran , Lanza, Ian R.

Mayo Clinic

JCI Insight | October 10, 2023 | Volume: 8 | Issue: 22 | Pages: No page available

10.1172/jci.insight.171772 | PMID 37815864 Get It

Aging and many illnesses and injuries impair skeletal muscle mass and function, but the molecular mechanisms are not well understood. To better understand the mechanisms, we generated and studied transgenic mice with skeletal muscle–specific expression of growth arrest and DNA damage inducible α (GADD45A), a signaling protein whose expression in skeletal muscle rises during aging and a wide range of illnesses and injuries. We found that GADD45A induced several cellular changes that are characteristic of skeletal muscle atrophy, including a reduction in skeletal muscle mitochondria and oxidative capacity, selective atrophy of glycolytic muscle fibers, and paradoxical expression of oxidative myosin heavy chains despite mitochondrial loss. These cellular changes were at least partly mediated by MAP kinase kinase kinase 4, a protein kinase that is directly activated by GADD45A. By inducing these changes, GADD45A decreased the mass of muscles that are enriched in glycolytic fibers, and it impaired strength, specific force, and endurance exercise capacity. Furthermore, as predicted by data from mouse models, we found that GADD45A expression in skeletal muscle was associated with muscle weakness in humans. Collectively, these findings identify GADD45A as a mediator of mitochondrial loss, atrophy, and weakness in mouse skeletal muscle and a potential target for muscle weakness in humans.
Fat-Free Mass Index in a Large Sample of National Collegiate Athletic Association Men and Women Athletes From a Variety of Sports
Magee, Meghan K., Fields, Jennifer B. , Jones, Margaret T. , Jones, Margaret T , Jagim, Andrew R.

Mayo Clinic

Journal of Strength & Conditioning Research | October 10, 2023 | Volume: 38 | Issue: 2 | Pages: 311-317

10.1519/jsc.0000000000004621 | PMID 37815277 Get It

Abstract Magee, MK, Fields, JB, Jagim, AR, and Jones, MT. Fat-free mass index in a large sample of National Collegiate Athletic Association men and women athletes from a variety of sports. J Strength Cond Res 38(2): 311–317, 2024—Fat-free mass index (FFMI) can be used to categorize fat-free mass (FFM) relative to height. Normative values have been established in a variety of sports, as has suggested lower and upper thresholds of FFMI. However, FFMI has not been reported in a large sample of athletes, representing both sexes and multiple sport types. The purpose of this study was to evaluate differences in FFMI and establish normative values across a large sample of collegiate sports. A total of 1,961 athletes (men: n = 596, 10 sports; women: n = 1,365, 8 sports) participated. Height and mass were measured using a stadiometer and calibrated digital scale, respectively. Fat-free mass was assessed with air displacement plethysmography and used to calculate FFMI. Kruskal-Wallis test and one-way analysis of variance evaluated differences in FFMI in women's and men's sports, respectively. When collapsed across sport type and stratified by sex, men had a higher FFMI (21.5 ± 1.9 kg·m −2 vs. 17.9 ± 1.8 kg·m −2 ; p < 0.001). Differences occurred in FFMI across sport. In women, basketball athletes had the highest FFMI (18.9 kg·m −2 ) and highest 99th percentile for FFMI, whereas rowers had the lowest (16.9 kg·m −2 ). In men, throwers had the highest FFMI (25.7 kg·m −2 ) and highest 99th percentile, whereas volleyball athletes had the lowest (19.9 kg·m −2 ). Differences in FFMI may be attributable to dietary habits and physiological demands of respective sports. These results can provide information relative to differences in FFMI values across sports. In addition, sport-specific normative values can be used as benchmarks and targets for training, nutrition, and goal setting.
EP212 Ilioinguinal Block with Liposomal Bupivacaine for Lower Extremities Revascularization: Have We Found the ‘Right’ Block?
Gurrieri, Carmelina , Almhanni, Ghaith , Sen, Indrani , Carmody, Thomas , Beckermann, Jason , Calvin, Andrew D. , Carmody, Thomas, Tallarita, Tiziano

Mayo Clinic

ePoster session 6 – Station 6 | October 10, 2023 | Volume: No volume available | Issue: No issue available | Pages: A155.3-A156

10.1136/rapm-2023-esra.272 Get It

Gluteal Tendinopathy
Dancy, Malik E. , Alexander, Andrew , Clark, Julian , Marigi, Erick M. , Hevesi, Mario , Levy, Bruce A. , Krych, Aaron J. , Okoroha, Kelechi R. , Alexander, Andrew S , Clark, Clarence Julian , Krych, Aaron J , Marigi, Erick , Hevesi, Mario

Mayo Clinic

JBJS Reviews | October 9, 2023 | Volume: 11 | Issue: 10 | Pages: No page available

10.2106/jbjs.rvw.23.00101 | PMID 37812677 Get It

» Gluteal tendinopathy/greater trochanteric pain syndrome (GTPS) is the most prevalent of all lower limb tendinopathies, affecting 1 in 4 women older than 50 years and commonly individuals within their fifth and sixth decades of life regardless of activity level. » The condition is believed to originate from age-related degenerative changes about the hip abductor tendon insertions and the surrounding bursae, and is exacerbated by congenital and acquired abnormal hip biomechanics. » Treatment of gluteal tendinopathy/GTPS often begins with noninvasive nonoperative modalities such as activity modifications, nonsteroidal anti-inflammatory drugs, and physical therapy. For recalcitrant symptoms, additional nonoperative therapies have been used; however, there remains a lack of comparative efficacy between these adjunct treatments. » In this article, we examine the available literature regarding the nonoperative management of gluteal tendinopathy/GTPS and provide insight into the effectiveness of current treatment modalities.